PALI

NASD Palisade Bio, Inc.
Sep 30, 2026 · 12:36 PM ET DELAYED Market Open

$1.40 ↓ -0.05 (-3.45%) Trading Down from the previous close of $1.45, $0.06 below the day’s high of $1.46

YTD change
-40.43%
vs 20-day SMA
-23.08%
vs 200-day SMA
-27.27%

Price ranges

Previous day
$1.42 $1.55
open $1.54 close $1.45
-$0.09 (-5.84%)
Today
$1.39 $1.46
open $1.44 now $1.40
-$0.04 (-2.78%)
Past week
$1.42 $1.70
from $1.69 now $1.40
-$0.29 (-17.16%)
Past month
$1.42 $2.24
from $1.95 now $1.40
-$0.55 (-28.21%)
This year
$1.39 $2.86
from $2.35 now $1.40
-$0.95 (-40.43%)

Price & Performance

-0.33 (-18.54%) / 6M

$1.34$1.86$2.39$2.91Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $8,182.50
  • PALI is down 40% since the beginning of the year
  • PALI is up 63% over the past 12 months
  • PALI is down 28% over the past 1 month
  • 14% of all PALI investors are betting against PALI

PALI reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +68.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.05
Earnings momentum +18.2% Quarterly EPS growth
Quarterly change +18.2%

Valuation

P/E ratio 2.42
Enterprise value $181.3M
Beta 1.19

Balance sheet & scale

IncomeN/A
Revenue$500.0K
Cash$125.2M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $296.9M

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies for inflammatory bowel diseases. Its programs include PALI-2108 and LB1148. The company was founded on September 6, 2011 and is headquartered in Denver, CO.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $423.64 +1.32%
MRNA Moderna, Inc. $203.46 +3.13%
RVMD Revolution Medicines, Inc. $204.48 +1.36%
ROIV Roivant Sciences Ltd. $36.50 -1.30%
BNTX BioNTech SE Sponsored ADR $98.57 -0.51%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.